Status:
NOT_YET_RECRUITING
Proteolytic Enzyme Fortified Protein Supplement in Chronic Pancreatitis.
Lead Sponsor:
Asian Institute of Gastroenterology, India
Conditions:
Chronic Pancreatitis
Malnutrition
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
A complex disease, Chronic Pancreatitis (CP) is caused by a wide range of factors, including smoking, alcoholism, autoimmune disorders, and obstruction of the major pancreatic duct. In patients who ar...
Detailed Description
Maldigestion due to pancreatic exocrine insufficiency (PEI) and food avoidance (because by pain) are two physical causes of malnutrition1. Delayed gastric emptying leads to nausea, vomiting, and poor ...
Eligibility Criteria
Inclusion
- Patients diagnosed with Chronic pancreatitis and on PERT.
- Patient who has given consent for the study.
- Participants who are greater 18yrs of age
- Patients on oral diet
- BMI less than ≤ 20kgs/m2
Exclusion
- Patients with hemodynamic instability.
- Patients with history of GI surgeries.
- Patients on immunosuppressants
- Patients having other malignancies.
- Participants who are allergic/ intolerance to any of the ingredients in the supplement
- Patients on enteral feeding or in combination with parenteral nutrition
Key Trial Info
Start Date :
September 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2025
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06585735
Start Date
September 1 2024
End Date
June 30 2025
Last Update
September 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Asian Institute of Gastroenterology Hospitals
Hyderabad, Telangana, India, 500032